COVID-19旅行限制解除后淋病奈瑟菌多样性增加及多重耐药株输入:观察性基因组流行病学研究
该研究分析澳大利亚南澳大利亚州常规公共卫生监测的淋病奈瑟菌基因组数据,并纳入维多利亚州背景序列,比较COVID-19州际和国际旅行限制解除前后的菌株群体结构。结果显示限制期间菌株高度克隆化,限制解除后基因组多样性显著增加,可能由传播增加和新菌株输入驱动。常规基因组监测对监测淋病奈瑟菌尤其耐药株输入和传播是重要公共卫生工具。
要点
- 旅行限制期间淋病奈瑟菌呈高度克隆化,解除后基因组多样性显著增加。
- 多样性增加可能源于传播增强和新菌株输入。
- 常规基因组监测有助于发现耐药淋病奈瑟菌的输入与传播。
核心结论
- COVID-19旅行限制解除后淋病奈瑟菌基因组多样性显著增加,可能由传播增加和新菌株输入驱动。
- 常规基因组监测是监测淋病奈瑟菌尤其抗菌药物耐药株输入和传播的重要公共卫生工具。
研究设计与样本
- 观察性基因组流行病学研究,分析澳大利亚南澳大利亚州常规公共卫生监测收集的淋病奈瑟菌基因组数据,并纳入维多利亚州背景序列,比较COVID-19州际和国际旅行限制解除前后的菌株群体结构。
主要发现
- 旅行受限期间淋病奈瑟菌高度克隆化。
- 旅行限制解除后基因组多样性显著增加,可能由传播增加和新菌株输入驱动。
临床怎么用
- 利用常规基因组监测追踪淋病奈瑟菌群体结构变化,重点关注耐药株的输入和传播。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: National and international travel drives the spread of antimicrobial resistance in high-priority pathogens, including Neisseria gonorrhoeae. Border closures and travel restrictions in response to the COVID-19 pandemic had wide-reaching impacts on infectious disease epidemiology, including the transmission and genomic diversity of N gonorrhoeae. However, less is known about N gonorrhoeae population structures in the years following the lifting of pandemic restrictions. METHODS: This study analyzed N gonorrhoeae genomic data collected for routine public health surveillance in South Australia, Australia, and contextual sequences from Victoria, Australia, before and after the cessation of COVID-19 interstate and international travel restrictions. RESULTS: N gonorrhoeae was highly clonal during periods with restricted travel, and genomic diversity markedly increased after restrictions were removed, possibly driven by increased transmission and the introduction of new strains. CONCLUSIONS: Routine genomic surveillance is an important public health tool for the monitoring of N gonorrhoeae, especially the introduction and spread of antimicrobial resistant strains.
引用
- Coldbeck-Shackley RC, Flynn E, Mudhar AK, et al. Increased Diversity and Introduction of Multidrug-Resistant Strains of Neisseria gonorrhoeae Following Cessation of COVID-19 Pandemic-Related Travel Restrictions: An Observational Genomic Epidemiologic Study. J Infect Dis. 2026. PMID: 41672099. doi:10.1093/infdis/jiag097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。